PTGES and graft versus host disease: showed that treating BM MSCs with IM or downregulating expression of prostaglandin E synthetase (PGES) via siRNA reduced proliferation of human PBMCs, and PGES knock down MSCs were unable to reduce mortality in mice with GVHD (72).